Study on QOL improvement with the glucide diet which enhanced protein and EPA in advanced colorectal cancer and breast cancer for stage IV
Phase 1
- Conditions
- colorectal cancer, breast cancer
- Registration Number
- JPRN-UMIN000029527
- Lead Sponsor
- Tama-Nanbu Regional Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation. Department of Surgery
- Brief Summary
A 3-month combination of the modified MCT ketogenic diet and chemotherapy was safe for stage IV cancer patients and allowed them to maintain quality of life. We believe that tumor reduction was associated with blood ketone body level.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Diabetic patient Cachexy patient
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The evaluation is every month after a glucide diet start. Blood sugar level, blood ketone body density, the weight, albumin level, renal function (BUN, Cr), liver function (GOT, GPT), QOL score)
- Secondary Outcome Measures
Name Time Method The evaluation is three month after a glucide diet start. The RECIST evaluation by the examination for CT. Change of the tumor marker